Hospital-based HIV/HSV-2 seroprevalence among male patients with anal disease in Korea: cross sectional study by Jin-Sook Wang et al.
RESEARCH ARTICLE Open Access
Hospital-based HIV/HSV-2 seroprevalence among
male patients with anal disease in Korea: cross
sectional study
Jin-Sook Wang1,2†, Do Yeon Hwang3†, Hye-Kyung Yu1, Sung Soon Kim1, Jong Kyun Lee3 and Mee-Kyung Kee1*
Abstract
Background: This study aimed to identify the characteristics of HIV and herpes simplex virus (HSV)-2
seroprevalence in male patients with anal disease.
Methods: HIV seroprevalence was estimated for different age groups of male patients with anal disease who were
treated at Songdo colorectal hospital in Korea between 2001 and 2011. HIV seroprevalence of patients with anal
disease was compared with that of patients with nonanal disease for each year from 2007 to 2011. HSV-2 antibody
tests were conducted on 2,038 HIV-tested male patients with anal disease in 2009.
Results: For 11 years from 2001, HIV seroprevalence differed significantly by age group (P < 0.001) and was highest in
the group aged <20 years. From 2007 to 2011, HIV seroprevalence in patients with anal disease was 7.6/10,000–13.3/
10,000 and that in patients with nonanal disease was 0–0.9/10,000. HSV-2 seroprevalence among patients with anal
disease was 24.0%, and only one patient with HIV and HSV-2 was observed.
Conclusions: HIV seroprevalencein male patients with anal disease was significantly higher than that for other diseases.
HSV-2 seroprevalence was similar to that in the general male population. Implementation of the current HIV surveillance
system for male patients at colorectal hospitals is necessary to help prevent HIV transmission.
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Background
When AIDS was first reported in 1981, it seemed to be a
new disease that affected only homosexual men. However,
it was discovered that the disease spread to the general
population through drug users, hemophilia patients,
children infected by their mothers, and sexual partners
of individuals with HIV through blood or sexual contact
[1]. Since 1985, when the first case of HIV infection
was identified in Korea, the number of HIV infections
has continued to increase, with the cumulative total
reaching 9,406 in 2012. The ratio of males to females
among reported HIV cases is approximately 11:1. Overall,
99% of HIV infections is caused by sexual contact, and
the proportion of cases attributed to male-to-male sexual
contact is about 40% [2]. Almost 70% of all newly identi-
fied cases is identified during hospital care [3]; thus, it
was of interest to identify the type of medical procedures
and treatment during which the highest number of new
HIV diagnoses was made. According to Miles et al. and
Wexner et al., 5.9–34% of the HIV-infected population
has anal disorders, which are also the most frequent cause
for surgery in this group [4,5]. Among men who have
sex with men attending a sexually transmitted infection
(STI) clinic, 30.8% had dysuria, pus, and urethral ulceration,
and 37.1% had pus, bleeding, ulceration, and/or pain in
the rectum [6]. A study of HIV infection and anal diseases
in Korea found that most HIV infections detected at
colorectal hospitals were in men, most of whom were
homosexual [7]. Currently, there are more males than
females HIV patients and the predominant route of
transmission is homosexual contact in Korea.
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Genital ulcers have been associated with increased risk
factors for HIV infection, and genital herpes is usually
caused by herpes simplex virus (HSV)-2 [8]. Our previ-
ous study had compared HSV-2 seroprevalence in HIV-
infected males with that in the general male population
in Korea, which was two or three times higher among
HIV-infected males [9]. HSV-2 seroprevalence had a
tendency to increase with age and HIV seroprevalence
had a different characteristic by age in most countries
including Korea [9-11].
Given these epidemiological characteristics of HIV
infection in Korea, we aimed to estimate HIV sero-
prevalence and trends among men suffering from anal
disease. We also aimed to identify the seroprevalence
of these sexually transmitted viruses by measure of
HSV-2 infection, a virus that is spread sexually.
Methods
Subjects
HIV seroprevalence in male patients who were treated
for anal disease at Songdo (S) colorectal hospital from
2001 to 2011 was estimated for different age groups. S
colorectal hospital is a representative large hospital
specializing in the field of anal diseases in Seoul, Korea.
HIV seroprevalence in male patients with anal disease was
compared with that in those who presented for other
reasons (including a health checkup) calculated for each
year from 2007 to 2011. To understand HIV and/or HSV-
2 seroprevalence, HSV-2 tests were conducted on 2,038
men who received treatment for anal diseases at S colorec-
tal hospital. The HSV-2 samples randomly selected among
26,173 male patients with anal disease tested for HIV in
2009. Ethics approval was obtained from KCDC Institu-
tional Review Board (IRB) Ethics Committee.
HIV and HSV-2 antibody tests
HIV screening was performed using Architect HIV AG/AB
Combo Kit (Abbott Laboratories, Abbot Park, IL, USA) to
determine the presence of HIV antibody and/or antigen.
Patient samples that tested positive in HIV screening
were subjected to an additional HIV western blot test
(HIV BLOT 2.2 Western Blot Assay, MP Diagnostics, Asia
Pacific Pte Ltd., Singapore) at an HIV confirmatory testing
institute to confirm HIV infection. HSV-2 antibody tests
were performed with the HerpeSelect 2 ELISA IgG Kit
(Focus Diagnostics, Cypress, CA, USA). HSV-2 results
were reported as an index value relative to the cut-off
calibrator. An index value >1.10 was presumptive for
the presence of IgG antibodies to HSV-2.
Statistical analysis
HIV seroprevalence was defined as the number of con-
firmed HIV cases per 10,000 HIV-tested people over a
1-year period. HSV-2 seroprevalence was defined as the
proportion of HSV-2-positive people among the total
number of people tested. Patients with any type of anal
disease were grouped together as the anal disease patients,
and patients who visited the hospital for a health checkup
or for another intestinal disorder were categorized as
the nonanal disease patients. Trend tests were conducted
to determine how HIV seroprevalence varied from year
to year in the anal and nonanal disease patients, using
SAS version 9.3. χ2 tests were used to compare HIV
seroprevalence in patients with anal disease and nonanal
disease, and HIV and HSV-2 seroprevalence in different
age groups of patients with anal disease, with a 95%
confidence level.
Results
Status of HIV tests and trends in HIV seroprevalence
S colorectal hospital administered HIV tests to 17,593–
30,225 male patients with anal disease every year from
2001 to 2011. Approximately 50% of total HIV tests
were performed in patients aged ≥50 years. Overall, 255
HIV-infected males were founded during the same period
(data not shown). As shown in Figure 1, annual HIV sero-
prevalence among male patients with anal disease during
the study period was 6.3–16.2 per 10,000. The trend
revealed that HIV seroprevalence was highest in the
group aged <20 years, followed by 20–29, 30–39, 40–49
and ≥50 years (P < 0.0001). Over 11 years, 1,254 teenagers
(approximately 0.5% of the total) were treated for anal
disorders and among these, 10 were diagnosed with HIV
(data not shown). The trend in HIV seroprevalence over
time did not show any specific pattern in any of the age
groups: under 20 (P = 0.5982), 20–29 (P = 0.3675), 30–39
(P = 0.7476), 40–49 (P = 0.1336), 50–59 (P = 0.0815),
and ≥60 (P = 0.3709) years.
As shown in Table 1, for the trend in HIV seropreva-
lence among male patients with anal or nonanal disease,
119 were found to be positive for HIV from 2007 to 2011.
One hundred and sixteen male patients with anal disease
were confirmed to have HIV (97% of total confirmed
infections). HIV seroprevalence in patients with anal
disease ranged from >10/10,000 in 2007 to 7.6/10,000
in 2011. Among patients with nonanal disease, three were
found to have HIV with an estimated seroprevalence of
0.5/10,000 in 2008 and 0.9/10,000 in 2010.
HIV and/or HSV-2 seroprevalence among patients with
anal disease
As shown in Table 2, of the 2,038 male patients with anal
disease, 1.8% were aged <20 years, 11.0% were 20–29 years,
20% were ≥30 years. Five men (25/10,000) were diagnosed
with HIV, three of whom were in their 20s, and one
each in the 30–39- and 40–49-year age groups. The
total HSV-2 seroprevalence was 24.0%: 5.4% for men
aged <20 years, 8.0% for those aged 20–29 years, and
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11.7% for those aged 30–39 years, with the rate increasing
with age (P < 0.0001). Infection with HIV and HSV-2 was
found in only one patient (4/10,000) of the total number
tested, who was in his 30s.
Discussion
In the present study, HIV seroprevalence among male
patients with anal disease was between 6.3/10000 and
16.2/10000, which was nearly 30 times higher than that of
male patients with nonanal disease at a colorectal hospital.
This indicates a strong association between anal disease
and HIV infection in male patients. Over the past 11 years
(Figure 1), HIV seroprevalence in male patients with
anal disease has decreased, although the status of HSV-2
seroprevalencehas remained at a level similar to that in
the general male population.
According to the Joint United Nations Programme on
HIV/AIDS (UNAIDS), HIV seroprevalence in Korea is at
a low epidemic level of between 1/10,000 and 4/10,000
[12,13]. However, the number of HIV-infected individuals
in Korea has continued to rise and isexpected to increase
further, for two main reasons. First, the HIV epidemic
pattern in Korea is similar to that observed in the early
1980s when HIV became a global pandemic. More specif-
ically, the epidemic pattern of HIV in Korea closely follows
the pattern of the early epidemiological stages of the
virus when HIV was spread mainly through sexual con-
tact, especially between men [14]. Second, in many of
the recently identified cases, the infections were discovered
long after onset. This means that the infected individuals
may have unknowingly transmitted the virus to other
people [3]. Moreover, an increasing number of HIV cases
are detected during health checkups and treatment of
Figure 1 Trends in HIV seroprevalence by age among male patients with anal diseases, 2001–2011. Annual HIV seroprevalence was 6.3 to
16.2 per 10,000 individuals.
Table 1 Trend in HIV seroprevalence among male patients with anal disease or with nonanal disease, 2007 - 2011
Year
With anal diseases With nonanal diseases
N (%)a HIV +b HIV seroprevalence per 10,000 N (%)a HIV +b HIV seroprevalence per 10,000
2007 23,861 (58.0) 24 10.1 17,274 (42.0) 0 0
2008 22,581 (54.3) 30 13.3 18,986 (45.7) 1 0.5
2009 26,173 (53.2) 20 7.6 23,000 (46.8) 0 0
2010 27,552 (56.3) 19 6.9 21,378 (43.7) 2 0.9
2011 30,225 (56.4) 23 7.6 23,382 (43.6) 0 0
HIV prevalence was defined as the number of confirmed HIV cases per 10,000 HIV-tested people over a 1-year period.
Nonanal diseases: patients who presented at the hospital with a nonanal disease or for a health checkup.
aN (%): the number of individuals tested for HIV (the proportion of patients with anal disease or nonanal disease).
bHIV+: the number of HIV-infected individuals.
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other conditions [13]. Therefore, the role of private
health-care institutions has become important in both
HIV treatment and diagnosis.
In a prior study that examined HIV seroprevalence
during 2002 and 2007, based on data collected from
colorectal hospitals across the country, HIV seroprevalence
was between 2.2/10,000 and 3.9/10,000, which was about
two or three times higher than that of all hospital patients
[13,15]. This study analyzed the characteristics of HIV
seroprevalence among patients in a colorectal hospital
according to variables including sex, age and presence
of anal disease. The results showed that most of the
cases of HIV were in patients who also had anal disease.
Overall, HIV seroprevalence in patients with anal disease
was ≈ 10/10000. In Korea, HIV seroprevalence was highest
among sexual partners of HIV-infected individuals
(>1,000/10,000), followed by people who applied vol-
untarily for HIV testing because they wanted to know
their status (>20/10,000), and people who underwent
additional HIV tests when their doctor suspected HIV
infection during treatment (>10/10,000) [11,16]. This
study showed that male patients with anal disease were
similar to those referred by their doctor and were assumed
to be a high-risk group.
In addition, male patients in whom HIV infection was
detected at the colorectal hospital tended to be younger
than the general HIV-infected male population, and HIV
seroprevalence increased significantly with younger age.
For specific identification of high HIV seroprevalence
in the group aged <20 years, we divided into groups
aged <10 years, 10–14 years and 15–19 years. From 2001
to 2011, 1,061 male patients aged 15–19 years were
treated and underwent HIV testing at the hospital. Ten
HIV infections were found in the group aged 15–19 years.
In Korea, the HIV-infected young men aged 15–19 years
accounted for 2.4% of the total number of HIV-infected
men as of 2011. Sixty percent of these were infected
through homosexual contacts, which is higher than the
overall percentage infected through homosexual contact
(43%) [17]. In the present study, male patients aged
15–19 years comprised 3.7% of the total number of
male patients with HIV and anal disease. This produced
a higher annual HIV seroprevalence than for any other
group nationwide in Korea.
A survey of male sexual behavior in Korea showed that
sexual activity began around age 16 years [18], and only
10–20% used condoms [19]. A survey of homosexual
behavior in Korea showed that 60% of participants had
a homosexual feeling before age 18 years [20]. It is
expected that the group aged 15–19 years is a group at
high risk for STI.
Approximately 70% of HIV-infected individuals in the
present study contracted the virus through homosexual
contact, according to the HIV database of KCDC. In Korea,
HIV infection was detected in many people who visited
HIV testing and consulting centers for homosexual people
(HIV-positive rate of 5.5%) [21]. However, the proportion
of homosexual men who tested for HIV over the past year
in Korea was lower than that in other countries including
Japan, China and the United States [22]. Moreover, nearly
half of all homosexual men in Korea said that they had
never tested for HIV [20]. Therefore, the present study
shows that ensuring that colorectal surgeons can easily
identify lesions associated with HIV infection in male
patients with anal disease is important for preventing
misdiagnosis or delayed diagnosis of HIV infection and
stopping its spread.
HSV-2 can often cause acute infection or remain inactive
until it is triggered by a decline in the immune system.
HSV-2 is the cause of >90% of anorectal infections and
frequently the source of proctitis in homosexual men
[23]. In homosexual men living in San Francisco, the
seroprevalence of HSV-2, HIV and HSV-2/HIV was
26.1%, 18.6% and 12.0%, respectively [24]. In male infected
with HIV by sexual contacts in Korea in 2003, HSV-2
seroprevalence (23.9–69.2%) was higher than that in the
general male population (6.8–26.0%) [9]. In the present
study, 20% of HIV-infected individuals were found to have
Table 2 HIV seroprevalence and HSV-2 seroprevalence by age among male patients with anal disease, 2009
Age No. (%) HIV +a HIV seroprevalence per 10000 HSV-2 +b HSV-2 seroprevalence (%)
Total 2,038 (100) 5 24.5 489 24.0
< 20 37 (1.8) 0 0 2 5.4
20–29 224 (11.0) 3 134 18 8.0
30–39 446 (21.9) 1 22 52 11.7
40–49 398 (19.5) 1 25 85 21.4
50–59 477 (23.4) 0 0 166 34.8
≥ 60 456 (22.4) 0 0 166 36.4
HIV seroprevalence was defined as the number of confirmed HIV cases per 10,000 of HIV-tested people.
HSV-2 seroprevalence was defined as the proportion of HSV-2-positive people. The 2,038 HSV-2 samples randomly selected among 26,173 male patients with anal
disease tested for HIV in 2009.
aHIV+: the number of HIV-infected individuals.
bHSV2: the number of HSV-2-infected individuals.
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HSV-2. Moreover, HSV-2 seroprevalence in male patients
with anal disease was similar to that in the general
male population.
The present study had the following limitations. First,
there is limited scope to generalize the findings of the
study, because the estimates of HIV seroprevalence were
based on data obtained from a single colorectal hospital
located in Seoul. However, the study did show the
trends, status, and characteristics of HIV seroprevalence
among male patients with anal disease. Second, although
the estimated HSV-2 seroprevalence in male patients
with anal disease was flawed because the results were
based on data from a single hospital during a limited
period, the estimate is important because it is believed
to be the first such study in Korea. Finally, we don’t have
data on sexual behavior to find out the reason of high
HIV seroprevalence among male patients with anal disease.
And, HSV-2 seroprevalence was low in male patients with
anal disease, which differed from other studies [25,26].
It will be necessary to establish the relationship between
the study results and the epidemiological characteristics
of the study subjects in Korea.
Conclusions
The HIV seroprevalence of male patients with anal disease
was significantly higher than that in patients with other
diseases. The high HIV seroprevalence in patients in a
colorectal hospital suggests the need to develop effective
prevention programs for sexually transmitted infections,
with a focus on hospitals specializing in anal diseases.
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